These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34225599)

  • 1. Monoamine Oxidase as a Potential Biomarker of the Efficacy of Treatment of Mental Disorders.
    Uzbekov MG
    Biochemistry (Mosc); 2021 Jun; 86(6):773-783. PubMed ID: 34225599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase activity and behavioral response to pharmacotherapy in psychiatric patients.
    Rosen AJ; Wirtshafter D; Pandey GN; Davis JM
    Psychiatry Res; 1982 Feb; 6(1):49-59. PubMed ID: 6120529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood platelet monoamine oxidase activity in psychiatric patients.
    Friedman E; Shopsin B; Sathananthan G; Gershon S
    Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
    [No Abstract]   [Full Text] [Related]  

  • 4. Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?
    Fowler CJ; Tipton KF; MacKay AV; Youdim MB
    Neuroscience; 1982 Jul; 7(7):1577-94. PubMed ID: 6956813
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase in schizophrenia.
    Belmaker RH; Reches A; Ebstein RP
    Lancet; 1977 Oct; 2(8042):821. PubMed ID: 71627
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man.
    Kleinman JE; Potkin S; Rogol A; Buchsbaum MS; Murphy DL; Gillin JC; Nasrallah HA; Wyatt RJ
    Science; 1979 Oct; 206(4417):479-81. PubMed ID: 504993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase activity during the course of a schizophreniform psychosis.
    Cookson IB; Owen F; Ridges AP
    Psychol Med; 1975 Aug; 5(3):314-6. PubMed ID: 1161970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric morbidity and platelet monoamine oxidase activity in cancer patients.
    Prasad A; Rampling RP; Glover V; Sandler M
    Psychiatry Res; 1987 Oct; 22(2):111-6. PubMed ID: 3685221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

  • 12. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatographic determination of inhibition of monoamine oxidase activity in platelet rich plasma of depressed patients treated with phenelzine.
    Gupta RN; Steiner M
    Clin Chim Acta; 1985 Oct; 152(1-2):63-9. PubMed ID: 4053406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients.
    Filinger EJ
    Gen Pharmacol; 1989; 20(6):821-2. PubMed ID: 2591711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated platelet monoamine oxidase activity in patients wth nonendogenous depression.
    White K; Shih J; Fong T; Young H; Gelfand R; Boyd J; Simpson G; Sloane RB
    Am J Psychiatry; 1980 Oct; 137(10):1258-9. PubMed ID: 7416279
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet monoamine oxidase activity as a biological marker in a Swedish forensic psychiatric population.
    Stålenheim EG; von Knorring L; Oreland L
    Psychiatry Res; 1997 Mar; 69(2-3):79-87. PubMed ID: 9109175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 18. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A; Mann J; Friedman E
    Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.